ALDR

AcronymDefinition
ALDRAnnual Load Data Request (Electric Reliability Council Of Texas, Inc.)
ALDRAmbient Light Digital Renderings Inc. (design company; Portland, OR)
ALDRAltitude Lost During Recovery
References in periodicals archive ?
For several individuals (n=4; IDs 64, 136, 137, and 151), their ALDR at Deep Point corresponded to seasonal ALR and original tagging location.
(NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will report its second quarter 2019 financial and operating results after the close of U.S.
Raymond, however, remains cautious on Teva shares given the" lack of clarity regarding when/where EBITDA will hit a trough." On the R&D side, the analyst notes that Overweight-rated Alder Biopharmaceuticals' (ALDR) eptinezumab "appears to be particularly top-of-mind among migraine specialists."
STATS PAC K MOTHERWELL TREVOR CARSON 8 RICHARD TAIT 8 Tom Aldr ed7 CEDRIC KIPRE 5 CHARLES DUNNE 6 CHRIS CADDEN 6 ALLAN CAMPBELL 6 CARL MCHUGH 6 ELLIOT FREAR6 RYAN BOWMAN 6 CURTIS MAIN 7 SUB: Stephen Hendrie (Frear 68) 4.
(Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today reported that the Compensation Committee of Alder's Board of Directors granted a non-qualified stock option to purchase an aggregate of 40,000 shares of Alder's common stock and an award of 20,000 restricted stock units ('RSUs') to a new employee under Alder's 2018 Inducement Award Plan, effective July 23, 2019 (the 'Grant Date').
Biohaven shares jump 21.5% after the news, while shares of Alder Biopharmaceuticals (ALDR), which also is in the migraine treatment space, were up 4.7%.
motherwell Trevor Carson 6 Cedric Kipre 6 Tom Aldr ed6 Ch arles Dunne 6 Liam Gr imsh aw 5 Richard Tait5 Carl McHugh5 Allan Campbell 6 Andy Rose 6 CRAIG TANNER6 CURTIS MAIN 6 SUBS: Gael Bigirimana (Rose 60) 3, Chris Cadden (Grimshaw 60) 3, Nadir Ciftci (McHugh 75) 2.
(NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that Bob Azelby, Alder's president and chief executive officer, will provide a business overview and update at the BMO Capital Markets 2019 Prescription for Success Healthcare Conference at 2:20 p.m.
Sandoval currently serves as CCO and executive VP of corporate strategy for Alder Biopharmaceuticals (ALDR).
Alder Biopharmaceuticals (ALDR) resumed with an Outperform at Wells Fargo.